objective Previous reviews on participants' comprehension of informed consent information have focused on developed countries. Experience has shown that ethical standards developed on Western values may not be appropriate for African settings where research concepts are unfamiliar. We undertook this review to describe how informed consent comprehension is defined and measured in African research settings.
Introduction
Comprehension is one of the essential elements of a truly informed consent. International ethical guidelines stipulate that informed consent must be given in a comprehensible manner to a competent person who freely decides to participate after understanding the information (NBAC 2001; CIOMS 2002; Marshall 2006) . However, the amount and quality of study information required to engender comprehension of a potential participant is unclear. There are also divergent opinions among researchers on the level of comprehension a potential participant should reach to be able to freely decide (Ijsselmuiden & Faden 1992; Hyder & Wali 2006) . In most African settings, the majority of research participants have low literacy, but informed consent documents are designed and delivered in a complex, lengthy manner that makes comprehension very challenging for the participants (Priestley et al. 1992; Jefford & Moore 2008; Falagas et al. 2009 ). In such settings, what constitutes 'satisfactory or adequate' comprehension of informed consent is vague (Sreenivasan 2003; Woodsong & Karim 2005) . This phenomenon has raised concerns about the quality and ethics of data generated from the increasing number of clinical trials being conducted in these low literacy communities (Annas 2009) .
A previous review of studies conducted in developed countries reported a lack of consensus definition of comprehension and an absence of a standardised tool to measure objectively the adequacy of participants' comprehension (Sand et al. 2010) . The authors concluded that a contextual definition of comprehension and systematic design of an instrument could guarantee adequate measurement of participants' comprehension (Sand et al. 2010; Mandava et al. 2012) . This underscores the need to contextualise the definition of comprehension of informed consent information for different research settings as this may inform the development of a locally acceptable, culturally sensitive measure of informed consent comprehension.
We undertook this review to examine how participants' comprehension of informed consent information has been defined and measured in clinical studies conducted in subSaharan Africa (SSA). This will be a major step towards reaching a consensus definition of informed consent comprehension in African research settings, which in turn will help to design improved informed consent procedures.
Methods

Literature search strategy
We searched five electronic databases for empirical studies on comprehension levels of different domains of informed consent among participants in SSA. The databases were Embase (1947 Embase ( -2010 , Medline (1960 ), Global Health (1960 , EthxWeb and Bioethics Literature Database (BELIT). To complement these databases, we also searched African Index Medicus (AIM) and Google Scholar for relevant bibliographies and grey literature. The last search was conducted on 11 October 2013. Studies were included if they satisfied the following three criteria:
• assessed or evaluated participants' comprehension of informed consent information;
• involved participants who were in clinical studies rather than hypothetical trials;
• were conducted in a SSA country.
The initial search was conducted on Ovid MEDLINE using a combination of medical subject headings (MeSH) and text words and then translated into the terms appropriate to Ovid Embase, Ovid Global Health, EthxWeb and BELIT. The AIM and Google scholar databases were also searched using text words. The search terms included (informed consent OR consent OR informed decision) AND (understanding OR comprehension OR retention OR knowledge OR awareness OR recall) AND (clinical trials OR clinical research OR randomi‫٭‬ed clinical trials). 'Sub-Saharan Africa' was searched using Africa south of Sahara OR developing countries OR low-income countries OR vulnerable population OR underserved population. To ensure all relevant countries were included in the review, sub-Saharan African countries listed in World RePORT database of global research (Collins et al. 2013) were used as a guide. Furthermore, to ensure the search was not limited to English language studies, specific Francophone and Lusophone country names such as Angola, Burkina Faso, Cape Verde, Cote d'Ivoire, Gabon, Guinea-Bissau, Mali, Mozambique, Sao Tome and Principe and Senegal were also included in the search terms. Specific search algorithms used in each database are presented in Table 1 .
Duplicate results from the searches were removed, and thereafter, the abstracts of retrieved articles were reviewed for relevance prior to accessing the full paper. We excluded letters or responses to published articles, commentaries and editorials. Conference abstracts that had not been published as full papers were included where the abstracts could be retrieved, provided that the abstracts had sufficient information for either qualitative or quantitative analysis. In situations where a conference abstract had been published as a full paper, the paper was retrieved and the conference abstract excluded. We contacted authors of conference abstracts whose full-paper publications could not be accessed to ask whether the abstract had been published as a full paper and if not, to seek more information about the study. Of five authors contacted, only one responded by providing the full text paper of the conference abstract. However, the published article provided by the author (Ravinetto et al. 2010) did not meet the eligibility criteria and was not included in the final analysis.
Data extraction
We obtained 245 articles from the primary search and 64 articles from AIM and Google scholar. Two of the review authors (MOA and JUO) independently screened the searches and applied the eligibility criteria. Of these 309 articles, 192 were removed because they were duplicates. Another 88 articles were sequentially excluded for the reasons of ineligibility. 29 studies satisfied the three inclusion criteria and were reviewed in detail. Figure 1 illustrates the inclusion process. Twenty-three of the studies were conducted in Anglophone countries (Abdool Karim et al. 1998; Leach et al. 1999; Joubert et al. 2003; Molyneux et al. 2004; Moodley et al. 2005; Pace et al. 2005; Marshall et al. 2006; Manafa et al. 2007; Hill et al. 2008; Minnies et al. 2008; Oduro et al. 2008; Taiwo & Kass 2009; Tekola et al. 2009; Vallely et al. 2010; Chaisson et al. 2011; Friedland et al., 2011a,b; Hussein & Ahmed 2011; Kiguba et al. 2012; Ndebele et al. 2012; Vreeman et al. 2012; Oria et al. 2013; Saidu et al. 2013) ; five in Francophone countries (Pr eziosi et al. 1997; CoulibalyTraore et al. 2003; Ekouevi et al. 2004; Krosin et al. 2006; Ellis et al. 2010 ) and one in a Lusophone country (Ciampa et al. 2012) . Similarly, 12 of these studies were conducted in West Africa (Pr eziosi et al. 1997; Leach et al. 1999; Coulibaly-Traore et al. 2003; Ekouevi et al. 2004; Krosin et al. 2006; Marshall et al. 2006; Manafa et al. 2007; Hill et al. 2008; Oduro et al. 2008; Taiwo & Kass 2009; Ellis et al. 2010; Saidu et al. 2013) , eight in East Africa (Molyneux et al. 2004; Pace et al. 2005; Tekola et al. 2009; Vallely et al. 2010; Hussein & Ahmed 2011; Kiguba et al. 2012; Vreeman et al. 2012; Oria et al. 2013) and nine in Southern Africa (Abdool Karim et al. 1998; Joubert et al. 2003; Moodley et al. 2005; Minnies et al. 2008; Chaisson et al. 2011; Friedland et al., 2011a,b; Ciampa et al. 2012; Ndebele et al. 2012) . Despite adoption of official languages of former colonial masters, countries in each subregion share similar sociocultural factors that may influence informed consent comprehension (Angell 1997; Annas 2009 ). Therefore, this review focused on a regional comparison rather than the adopted official languages.
We extracted information on the type and sites of the studies, the sample size, definition of understanding/comprehension as provided by the authors, method and timing of evaluation of participants' comprehension. Also retrieved were data on participants' understanding/comprehension of study information including key concepts of informed consent: study nature and purpose, blinding, placebo, randomisation, voluntariness, rights of withdrawal, benefits/risks and adverse events. We performed a detailed descriptive analysis and head-to-head comparison of study design, timing of informed consent, categories of participants recruited, instruments used for assessments and domains of informed consent assessed in each study (see Table 2 ). Because only three authors provided a full questionnaire in their papers (Krosin et al. 2006; Minnies et al. 2008; Ellis et al. 2010 ), we did not analyse the few questionnaires for data extraction. We based our comparison on results provided in the papers included in this review.
Meta-analysis
We conducted meta-analyses of summary statistics from 21 studies (Abdool Karim et al. 1998; Joubert et al. 2003; Ekouevi et al. 2004; Moodley et al. 2005; Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Manafa et al. 2007; Minnies et al. 2008; Oduro et al. 2008; Taiwo & Kass 2009; Ellis et al. 2010; Vallely et al. 2010; Chaisson et al. 2011; Friedland et al., 2011a, b; Hussein & Ahmed 2011; Kiguba et al. 2012; Ndebele et al. 2012; Oria et al. 2013; Saidu et al. 2013) which provided comprehension or understanding levels of participants on different domains of informed consent. Studies which used qualitative methods for assessments of comprehension (n = 7; Pr eziosi et al. 1997; Leach et al. 1999; Coulibaly-Traore et al. 2003; Molyneux et al. 2004; Hill et al. 2008; Tekola et al. 2009; Vreeman et al. 2012) and one with insufficient information (Ciampa et al. 2012) were excluded from the meta-analysis. Owing to differences in methods of outcome assessments (understanding scores or percentages of participants who demonstrated understanding), we generated the proportions of participants who had 'understanding' and 95% confidence intervals (95% CI) for each domain of informed consent. Random effects meta-analysis was used to pool the estimates of proportions across the studies because heterogeneity of study participants, study designs and assessment tools was envisaged. We estimated heterogeneity statistically using I squared statistics, which is the proportion of true heterogeneity that could be explained by chance (Higgins et al. 2003) . Expectedly, I squared statistics revealed a substantial heterogeneity in all domains of informed consent assessed (I 2 = 98-99%, P < 0.0001). Tables 3 and 4 summarise the meta-analytic results. The meta-analysis was conducted using MedCalc statistical software version 12.7.7 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org, 2013). Table shows that about 80% of study participants across the studies understood compensation and voluntariness, while only 30% understood therapeutic misconception, 55% understood confidentiality and <60% understood right to withdraw. 
Results
Study characteristics and design
Twenty-nine studies conducted in 20 countries from SSA examined participants' comprehension of informed consent information in clinical research on vaccines, tuberculosis treatment in HIV-infected patients, HIV prevention trials, male circumcision scale-up, oral health, vitamin A supplementation, immune correlates in paediatric age group and genetic studies of hypertension ( Table 2 ). The number of study participants in the studies ranged from 36 to 5755. Of the studies, 17 interviewed participants close to the time of consent (Abdool Karim et al. 1998; Leach et al. 1999 
Measurement tools
Sixteen studies used questionnaires to assess participants' comprehension (Abdool Karim et al. 1998 Kiguba et al. 2012; Ndebele et al. 2012; Oria et al. 2013; Saidu et al. 2013) ; six employed in-depth qualitative interviews (Leach et al. 1999; Coulibaly-Traore et al. 2003; Molyneux et al. 2004; Pace et al. 2005; Hill et al. 2008; Tekola et al. 2009 ) and five used both qualitative and quantitative methods Taiwo & Kass 2009; Vallely et al. 2010; Friedland et al., 2011a,b) and two used community group discussions Table shows that about 50% of participants across various studies understood placebo, randomisation and risks, while higher proportions (about 70%) understood benefits, blinding and study procedure. (Pr eziosi et al. 1997; Vreeman et al. 2012) . The majority of the questionnaires used closed-ended response formats. The questionnaires varied significantly in the number of items, and the domains addressed by these items. The authors indicated the number of question items in eight studies (Moodley et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Minnies et al. 2008; Ellis et al. 2010; Chaisson et al. 2011; Friedland et al., 2011a,b) ; the number ranged from 3-to 20-item quiz. The items in the questionnaire could be classified into two broad domains: generic and trial-specific questions (Joffe et al. 2001) . The generic questions focused on general aspects of research such as confidentiality, compensation, rights of withdrawal or refusal (Table 3) , while the trial-specific questions focused on individual research-related domains such as study purpose, study rationale, study procedures, medications, risks and adverse events (Table 4) . A complete questionnaire was included in the appendix in three papers (Krosin et al. 2006; Minnies et al. 2008; Ellis et al. 2010) . Participants were assessed on several domains of informed consent, while two studies (Tekola et al. 2009; Vallely et al. 2010) focused only on participants' understanding of therapeutic misconception. The format adopted in the semistructured or in-depth interviews was not clearly discussed in most of the papers except one study (Vallely et al. 2010 ) which used a standardised interview guide.
Development of measurement tools
Only four manuscripts (Krosin et al. 2006; Vallely et al. 2010; Ciampa et al. 2012; Ndebele et al. 2012) provided an account of how the measurement instrument was developed. One study (Taiwo & Kass 2009 ) mentioned that the questionnaire was adapted from previously developed questionnaires such as the Quality Questionnaire of Informed Consent and the Deaconess Informed Consent Questionnaire. Another study (Ciampa et al. 2012) adapted and validated its questionnaire from the Wide Range Achievement Test. Ten reported that they translated and back-translated the questionnaires from foreign languages to participants' local languages (Joubert et al. 2003; Moodley et al. 2005; Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Oduro et al. 2008; Chaisson et al. 2011; Ciampa et al. 2012; Kiguba et al. 2012; Ndebele et al. 2012 ). Significant linguistic diversity made it costly and logistically challenging to translate informed consent documents from English, French or Portuguese into effective written versions of several local languages of participants in each country (Pr eziosi et al. 1997; Tekola et al. 2009; Chaisson et al. 2011; Ciampa et al. 2012; Ndebele et al. 2012) .
In three studies, participants' comprehension was measured by the proportion of correct responses to the question items (Krosin et al. 2006; Oduro et al. 2008; Ellis et al. 2010) , while other studies assessed proportions of participants who gave correct responses to questionnaires and interviews (Joubert et al. 2003; Ekouevi et al. 2004; Moodley et al. 2005; Marshall et al. 2006) . Additionally, terms such as 'understanding', 'comprehension', 'knowledge', 'remembering', 'retention', 'recall, 'awareness' or 'recognition' were used interchangeably without clear definitions. Only one study (Minnies et al. 2008) defined the outcome variables: recall as 'success in selecting the correct answers in the question items' and understanding as 'correctness of interpretation of statements presented in the question items'. There was also no consensus on the time points to measure comprehension as participants (Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Sand et al. 2010; Friedland et al., 2011a,b) were evaluated at different times. Study purpose. Meta-analytic results showed that 65% of a total of 12 382 participants in 17 studies (Abdool Karim et al. 1998; Joubert et al. 2003; Ekouevi et al. 2004; Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Manafa et al. 2007; Minnies et al. 2008; Taiwo & Kass 2009; Ellis et al. 2010; Chaisson et al. 2011; Friedland et al., 2011a,b; Hussein & Ahmed 2011; Ndebele et al. 2012; Oria et al. 2013; Saidu et al. 2013 ) understood the purpose of the studies they were involved in (95% CI 34.9-89.4%). Furthermore, on descriptive comparison, comprehension of study purpose assessed in 18 studies (Pr eziosi et al. 1997; Abdool Karim et al. 1998; Leach et al. 1999; Coulibaly-Traore et al. 2003; Joubert et al. 2003; Ekouevi et al. 2004; Molyneux et al. 2004; Moodley et al. 2005; Pace et al. 2005; Krosin et al. 2006; Marshall et al. 2006; Manafa et al. 2007; Hill et al. 2008; Taiwo & Kass 2009; Chaisson et al. 2011; Ciampa et al. 2012; Kiguba et al. 2012; Saidu et al. 2013) was markedly high among participants in southern Africa (Minnies et al. 2008; Tropical Friedland et al., 2011a,b) . This ranged from 88% to 98.7%, while East and West African participants had comprehension rates between 8% and 47% (Joubert et al. 2003; Molyneux et al. 2004; Taiwo & Kass 2009; Kiguba et al. 2012) . Most participants in countries with poorer comprehension had a low level of education. Endemicity of the conditions studies also explained the disparities in the observed responses. For instance, there were marked differences in comprehension of the causes, routes of transmission and prevention of HIV by pregnant women in Cote . Inadequate access to health care and other poor socio-economic factors in developing countries were reported as strong motives for joining clinical trials (Pr eziosi et al. 1997; Leach et al. 1999) . Severity of diseases also contributes to the sense of compulsion to participate. In a Kenyan study, only 4% of mothers of seriously ill children agreed that participation was voluntary, while most participants believed that they would have been chased away if they refused to join the study (Molyneux et al. 2004) . In contrast, 97% of mothers whose children were less seriously sick in the same study reported voluntary participation during admission; 14% spontaneously reported this on discharge and 59% after prompting (Molyneux et al. 2004) . Karim et al. 1998; Ekouevi et al. 2004; Pace et al. 2005; Krosin et al. 2006; Manafa et al. 2007; Oduro et al. 2008; Ellis et al. 2010) showed that understanding of the right to withdraw from a study was low among most study participants across West African subregion. In a Malian trial (Krosin et al. 2006) , participants believed that leaving before the end of the study would be disrespectful to the investigators who might consequently deny them medical benefits associated with participation. Their counterparts from a South African (Abdool Karim et al. 1998 ) study showed better comprehension of their rights to stop participation. Similar trends were observed for rights of refusal to participate. Taiwo and Kass (2009) reported that social status in the study community might positively influence a participant to enrol in a study. One example was cited of a highly educated community officer who enrolled in a trial so as not to discourage other community members from joining the trial. Participants in a Gambian study (Leach et al. 1999 ) also expressed the fear of serious, unknown side effects of an experimental vaccine as a major reason for declining to enrol in the study.
Comprehension of informed consent information
Confidentiality. Meta-analytic results showed that 55% of a total of 1775 participants in four studies (Minnies et al. 2008; Oduro et al. 2008; Taiwo & Kass 2009; Saidu et al. 2013) did not understand the concept of confidentiality. However, descriptive comparison showed a high level of comprehension in two studies (Minnies et al. 2008; Saidu et al. 2013 ), but in other two studies (Taiwo & Kass 2009; Kiguba et al. 2012 ), participants were not aware of how their research records would be kept.
Compensation. Across three studies (Krosin et al. 2006; Oduro et al. 2008; Chaisson et al. 2011) involving 2428 participants, 76% understood compensation (95% CI 39.0-98.5%). Understanding of compensation associated with participation was largely dependent on how the questions were framed and presented to the participants, who generally considered personal benefit a high priority. Participants in two studies (Oduro et al. 2008; Chaisson et al. 2011 ) misunderstood reimbursement of transport fares as payment for study participation.
Risks. About 51% of 3419 participants understood risks involved in study participation (95% CI = 32.1-70.2%) in 10 studies (Leach et al. 1999; Molyneux et al. 2004; Pace et al. 2005; Krosin et al. 2006; Manafa et al. 2007; Minnies et al. 2008; Taiwo & Kass 2009; Ellis et al. 2010; Chaisson et al. 2011; Kiguba et al. 2012) . This was found to be better among participants from southern Africa (Minnies et al. 2008; Chaisson et al. 2011 ) than among participants in West African studies (Krosin et al. 2006; Taiwo & Kass 2009 ).
Therapeutic misconception. Only 30% of 753 participants across five studies (Ekouevi et al. 2004; Moodley et al. 2005; Krosin et al. 2006; Manafa et al. 2007; Tai-wo & Kass 2009 ) understood the concept of therapeutic misconception. This occurs when participants believe that the study is solely aimed at providing health care rather than generating research data. It featured prominently among West African participants (Ekouevi et al. 2004; Krosin et al. 2006; Manafa et al. 2007; Taiwo & Kass 2009) , while a South African study (Moodley et al. 2005) reported that a significant proportion of participants recognised they were participating in a research as opposed to seeking medical care.
Randomisation and placebo. Of 1633 participants in four studies (Moodley et al. 2005; Pace et al. 2005; Krosin et al. 2006; Ellis et al. 2010) , 47% demonstrated understanding about randomisation (95% CI = 13.9-80.9%). Similarly, 48% of 3946 participants in six studies (Moodley et al. 2005; Pace et al. 2005; Manafa et al. 2007; Vallely et al. 2010; Chaisson et al. 2011; Ndebele et al. 2012) had understanding of placebo (95% CI 0.19.0-77.5%).
Descriptive comparison showed that methods employed in explaining the concepts of randomisation and use of placebo during informed consent process influenced participants' understanding. Malawian participants (Ndebele et al. 2012 ) demonstrated good understanding of randomisation when a locally designed narrative was used to illustrate the research terms. About 75-78% of these participants comprehended randomisation and placebo, while 10-19% of East and West African participants demonstrated good understanding of the concepts (Leach et al. 1999; Pace et al. 2005; Hill et al. 2008) .
Autonomy/decision-making. Seven studies (Leach et al. 1999; Coulibaly-Traore et al. 2003; Ekouevi et al. 2004; Molyneux et al. 2004; Krosin et al. 2006; Friedland et al., 2011a,b) assessed this concept. Ninety-nine percentage of Gambian participants (Leach et al. 1999) submitted that parents and village leaders were involved in decision-making. Similar patterns were reported in East and other West African studies (Ekouevi et al. 2004; Molyneux et al. 2004; Krosin et al. 2006) , while individual decision-making was common in southern African countries (Friedland et al., 2011a,b) .
Predictors of comprehension. In most studies reviewed (Oduro et al. 2008; Taiwo & Kass 2009; Chaisson et al. 2011; Kiguba et al. 2012; Ndebele et al. 2012) , demographic variables like age and literacy did not show statistical significance, but male sex was reported as the only independent predictor of higher comprehension scores in one study (Ellis et al. 2010) . Conversely, primary education and residence in urban areas were predictors of understanding among women (Hill et al. 2008) . Similarly, another study (Krosin et al. 2006 ) reported higher comprehension scores in most urban participants than their rural counterparts. Among Mozambican participants, numeracy level was significantly associated with comprehension of study purpose and this was independent of respondent's age, income, distance from the hospital and the language of survey administration (Ciampa et al. 2012) . Moodley et al. (2005) also reported a positive linear correlation between participants' comprehension scores and their mini-mental state examination scores.
Discussion
To our knowledge, this is the first comparison of participants' comprehension of informed consent information in studies conducted across SSA. Previous reviews have either concentrated on informed consent comprehension in developed countries (Sand et al. 2010) or compared the quality of informed consent between Western and developing countries in Africa and Asia (Mandava et al. 2012) . Our review reveals that the methods used for assessing participants' comprehension differed significantly. Such variations in methodology limited comparison of findings and raise challenges about how to measure comprehension of informed consent information. Very few studies (Ciampa et al. 2012; Ndebele et al. 2012 ) described the format and justifications for deciding to use a set of question items. A sizeable proportion of the tools were developed ad hoc for each study without following standard guidelines of instrument development and validation.
We also identified a lack of a uniform definition of comprehension as studies in the review used the term 'comprehension' to mean 'understanding' or 'recall' or 'retention' or 'knowledge'. It is important to establish a distinction between these terms as it would help in developing a uniform definition for the concept. This effort is capable of providing an acceptable method for determining how an instrument can be constructed, implemented, interpreted and applied to measure the concept (Spreitzer & Sonenshein 2004) .
The domains of informed consent assessed by the studies also vary considerably with little regard to the crucial information that could engender comprehension. There is a need to develop guidelines that define the most crucial information relevant for comprehension of informed consent in African research settings as well as the best way this information should be communicated.
Most study participants in this review did not understand the distinction between research participation and seeking medical care. This concept of therapeutic misconception has been documented among participants in resource poor settings where inadequate access to health care exists (Appelbaum et al. 1982; Pr eziosi et al. 1997) . This is due to a mix of heavy burden of disease, poor access to health care, poor education, low literacy levels and the overriding impact of illness, suffering and poverty on decision-making. A National Bioethics Advisory Commission reported that therapeutic misconception does not imply that participants will most likely get adequate clinical care during research, but subsists when participants believe that the sole aim of clinical trials is to provide treatment rather than collect data (NBAC 2001) . Consequently, African researchers should strive to harmonise the research of essential medicines with the ethical requirements of making them accessible. Improved access to such care could reduce vulnerability and ultimately improve comprehension of African participants.
The time interval between informed consent process and assessment of comprehension in most of the studies was long, some more than 14 months after the trials have ended. Given the background of low literacy among participants, and not being familiar with research terms, it is very unlikely that reliable inferences can be drawn from assessments carried out after such long periods. There are no existing guidelines on the timing of such assessments as these are likely to be study or context specific.
Availability of the questionnaires in local languages was reported to aid participants' understanding in few countries (Chaisson et al. 2011; Ndebele et al. 2012) . However, this is not always possible as some African languages are spoken and do not have standardised writing formats. Translations and back-translation of informed consent documents are practically challenging in the Gambia for this reason.
A major strength of this review is the combination of meta-analytic results with the narrative comparison of the findings. This provided a robust summary of the findings on informed consent comprehension despite significant disparities in methodologies and heterogeneity of the data. Further contributing to this, we excluded participants in hypothetical studies so that our findings could reflect true clinical research situations as much as possible. We also included studies where participants were legally and cognitively competent, to remove factors which might confound our findings.
Limitations
Very few of the studies included in this review provided adequate information on the instruments employed to assess comprehension of informed consent. This did not permit analysis of wordings of the questionnaires to establish what the authors actually explored in their studies. Such analysis could have provided useful insights that might have contributed to appropriate interpretations of findings of the studies.
Also, findings of this review need to be cautiously interpreted because majority of the quantitative instruments used in this review contained closed-ended questionnaires, which are known to be an imperfect method of assessing comprehension, because respondents could guess answers correctly or provide socially desirable responses. This could have over-estimated the comprehension levels, thereby leading to inaccuracies in our findings. Studies (OnvomahaTindana et al. 2006; Ndebele et al. 2012) have shown that requesting participants to explain, using their own words, their comprehension of study information may truly manifest what participants understand.
It could also be inferred that studies in this review examined the 'performance' of participants, but apparently did not evaluate the communication skills of the researchers administering the consent; and this plays a key role for comprehension. This may represent an asymmetry, where researchers ask 'why participants do not comprehend' but we do not ask ourselves 'why are we not good at explaining crucial information to our participants?' Nevertheless, the representativeness of studies in this review provides a comprehensive knowledge base for setting research agenda and plans.
Conclusions
Our review confirmed the findings of previous reviews that comprehension of informed consent in Africa settings varies from country to country with relatively better comprehension among participants in southern Africa. Tools for measuring participants' comprehension are neither validated nor standardised. To overcome potential pitfalls in effectiveness of conventional informed consent procedures in African research settings, it is crucial to engage a body of knowledge on the development of clear guidelines to design adequate tools for improving informed consent comprehension and maximise the voluntariness of the choice to participate in clinical trials. Such tools should translate the respect for fundamental ethical principles, by taking into considerations local cultural values and constraints.
Furthermore, due to wide linguistic variability that made effective translations of informed consent documents to local languages challenging, appropriately developed tools using orally interpreted procedure with non-verbal support like video and animations may improve the comprehensibility of unfamiliar research concepts among African participants. Experts who are familiar with the local context and influence of communication and demographic factors on informed consent process need to be involved in the design. This multidisciplinary approach should harmonise local contextual and behavioural factors, including the expectations of the community, in developing comprehensible consent tools.
